The Free-To-Total Prostate Specific Antigen Ratio Improves the Specificity of Prostate Specific Antigen in Screening for Prostate Cancer in the General Population
- 1 June 1997
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 157 (6), 2191-2196
- https://doi.org/10.1016/s0022-5347(01)64712-8
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screeningJAMA, 1995
- European randomized study of screening for prostate cancer. Progress report of Antwerp and Rotterdam Pilot studiesCancer, 1995
- The Use of Age-Specific Reference Ranges for Serum Prostate Specific Anitgen in Men 60 years Old or OlderJournal of Urology, 1995
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference rangesJAMA, 1993
- Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate CancerJournal of Urology, 1993
- Serum Prostate Specific Antigen as Pre-Screening Test for Prostate CancerJournal of Urology, 1992
- Screening for Prostatic Carcinoma with Prostate Specific AntigenJournal of Urology, 1992
- The Use of Prostate Specific Antigen Density to Enhance the Predictive Value of Intermediate Levels of Serum Prostate Specific AntigenJournal of Urology, 1992